TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 15998754

Group type: EXPERIMENTAL
Intervention: Standard HIV testing
Number of subjects: 6000

Group type: EXPERIMENTAL
Intervention: Rapid HIV testing
Number of subjects: 6000

Group type: EXPERIMENTAL
Intervention: Combination antiretroviral regimens, elective cesarean section in selected patients, avoidance of breastfeeding
Number of subjects: 6000

Group type: EXPERIMENTAL
Intervention: Opt-out testing policies
Number of subjects: 6000

Group type: COMPARATOR
Intervention: Targeted screening based on risk factors
Number of subjects: 6000

Group type: COMPARATOR
Intervention: Untreated HIV infection
Number of subjects: 6000
Study: 12841803

Group type: EXPERIMENTAL
Intervention: Exposure to direct-to-consumer advertisements for osteoporosis drugs
Number of subjects: 51
Study: 11815322

Group type: EXPERIMENTAL
Intervention: Zinc supplementation (10 mg elemental Zn/d in cherry syrup)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Control group (cherry syrup alone)
Number of subjects: 42
Study: 10414395

Group type: EXPERIMENTAL
Intervention: Fluticasone propionate (FP)
Number of subjects: 69

Group type: COMPARATOR
Intervention: Beclomethasone dipropionate (BDP)
Number of subjects: 69
Study: 8775955

Group type: EXPERIMENTAL
Intervention: Direct referral to oral and maxillofacial surgery
Number of subjects: 0

Group type: COMPARATOR
Intervention: Routine A&E procedure
Number of subjects: 0
Study: 2139283

Group type: EXPERIMENTAL
Intervention: 40 micrograms dose, 4 dose vaccination schedule
Number of subjects: 270

Group type: COMPARATOR
Intervention: 40 micrograms dose, 3 dose vaccination schedule
Number of subjects: 270

Group type: EXPERIMENTAL
Intervention: 40 micrograms dose, 0, 1, 2, 6 month schedule
Number of subjects: 270

Group type: COMPARATOR
Intervention: 40 micrograms dose, 0, 1, 2, 12 month schedule
Number of subjects: 270

Group type: COMPARATOR
Intervention: 20 micrograms dose
Number of subjects: 270
Study: 7018854

Group type: EXPERIMENTAL
Intervention: 500 mg Ro 13-9904
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: 250 mg Ro 13-9904
Number of subjects: 45

Group type: COMPARATOR
Intervention: 80 mg tobramycin
Number of subjects: 45
Study: 6368877

Group type: EXPERIMENTAL
Intervention: Acyclovir (200 mg) five times daily for five days
Number of subjects: 250

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 250
Study: 29017191

Group type: EXPERIMENTAL
Intervention: Mobile mindfulness training app '7mind' for 14 days
Number of subjects: 306

Group type: COMPARATOR
Intervention: Wait-list control group (access to the app after study)
Number of subjects: 306
Study: 26302669

Group type: EXPERIMENTAL
Intervention: Quadratus lumborum block
Number of subjects: 104

Group type: COMPARATOR
Intervention: Femoral block
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 104
Study: 24906976

Group type: EXPERIMENTAL
Intervention: Metformin (M) 2 g/day
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Metformin (M) 2 g/day + Oral contraceptive pills (OCP) (150 mg desogestrel + 30 microgram ethinylestradiol)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Oral contraceptive pills (OCP)
Number of subjects: 90
Study: 23061303

Group type: EXPERIMENTAL
Intervention: Active tDCS
Number of subjects: 42

Group type: COMPARATOR
Intervention: Sham tDCS
Number of subjects: 42
Study: 19924003

Group type: EXPERIMENTAL
Intervention: BOSU balance trainer (both sides)
Number of subjects: 20
Study: 17891043

Group type: EXPERIMENTAL
Intervention: Standard clinic‐based patient education (SC) plus structured proactive telephone calls
Number of subjects: 109

Group type: COMPARATOR
Intervention: Standard clinic‐based patient education (SC)
Number of subjects: 109
Study: 16866809

Group type: EXPERIMENTAL
Intervention: One-on-one teaching
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: Group teaching
Number of subjects: 67

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 67
Study: 14702000

Group type: EXPERIMENTAL
Intervention: Mycophenolate mofetil (MM)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11
Study: 10905421

Group type: EXPERIMENTAL
Intervention: Abuse-focused cognitive behavioral therapy
Number of subjects: 49

Group type: COMPARATOR
Intervention: Nondirective supportive therapy
Number of subjects: 49
Study: 9173335

Group type: EXPERIMENTAL
Intervention: Phenytoin (PHT)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Carbamazepine (CBZ)
Number of subjects: 64
Study: 10145582

Group type: EXPERIMENTAL
Intervention: Open Spacer (OS)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Volumatic Spacer
Number of subjects: 16

Group type: COMPARATOR
Intervention: Nebuhaler Spacer
Number of subjects: 16

Group type: COMPARATOR
Intervention: Inspirease Spacer
Number of subjects: 16
Study: 2408515

Group type: EXPERIMENTAL
Intervention: 300 mg t.i.d. tritoqualine for three days
Number of subjects: 44

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: 300 mg t.i.d. tritoqualine for three days (in patients with a history of allergy)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Placebo (in patients with a history of allergy)
Number of subjects: 44
Study: 30772941

Group type: EXPERIMENTAL
Intervention: Sunitinib (50 mg daily in 6-week cycles: 4 weeks on treatment, 2 weeks off treatment)
Number of subjects: 1124
Study: 28621083

Group type: EXPERIMENTAL
Intervention: Social Communication Intervention Programme (SCIP)
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: SCIP intervention
Number of subjects: 5
Study: 27094801

Group type: EXPERIMENTAL
Intervention: Pregabalin with pulsed radiofrequency
Number of subjects: 60

Group type: COMPARATOR
Intervention: Pregabalin with sham treatment
Number of subjects: 60
Study: 24657428

Group type: EXPERIMENTAL
Intervention: CF-guided CPVI
Number of subjects: 38

Group type: COMPARATOR
Intervention: Non-CF-guided CPVI
Number of subjects: 38
Study: 22383680

Group type: EXPERIMENTAL
Intervention: Zoledronic acid (ZOL) plus adjuvant systemic therapy
Number of subjects: 96

Group type: COMPARATOR
Intervention: Adjuvant systemic therapy alone (Control)
Number of subjects: 96
Study: 20440122

Group type: EXPERIMENTAL
Intervention: Continuous-running training group (CTG)
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Intermittent-running training group (ITG)
Number of subjects: 63

Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 63
Study: 18990766

Group type: EXPERIMENTAL
Intervention: Serum vitamin B6
Number of subjects: 278

Group type: EXPERIMENTAL
Intervention: Serum folate
Number of subjects: 278

Group type: EXPERIMENTAL
Intervention: Other serum biomarkers (vitamin B12, riboflavin, homocysteine)
Number of subjects: 278

Group type: EXPERIMENTAL
Intervention: A priori combinations of the five one-carbon serum biomarkers
Number of subjects: 278
Study: 15817867

Group type: EXPERIMENTAL
Intervention: Multivitamins (MV)
Number of subjects: 886

Group type: EXPERIMENTAL
Intervention: Preformed vitamin A + beta-carotene (VA/BC)
Number of subjects: 886

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 886
Study: 12859466

Group type: EXPERIMENTAL
Intervention: Remifentanil 1 microg.kg‐1 (group R)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Saline 1 ml.kg‐1 (group S)
Number of subjects: 40
Study: 11040906

Group type: EXPERIMENTAL
Intervention: 2% prilocaine
Number of subjects: 125

Group type: COMPARATOR
Intervention: 2% lignocaine
Number of subjects: 125
Study: 8969724

Group type: EXPERIMENTAL
Intervention: Continued penicillin prophylaxis
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 0
Study: 1292762

Group type: COMPARATOR
Intervention: Retinoids or carotenoids
Number of subjects: 0

Group type: COMPARATOR
Intervention: Untreated control group or placebo control group
Number of subjects: 0
Study: 6209900

Group type: EXPERIMENTAL
Intervention: Meclosorb cream
Number of subjects: 60

Group type: COMPARATOR
Intervention: Tetracycline tablets (500 mg daily)
Number of subjects: 60
Study: 29459665

Group type: EXPERIMENTAL
Intervention: Aprepitant, ondansetron, and dexamethasone
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo, ondansetron, and dexamethasone
Number of subjects: 40
Study: 28165347

Group type: EXPERIMENTAL
Intervention: Google Glass group
Number of subjects: 42

Group type: COMPARATOR
Intervention: Control group (usual care)
Number of subjects: 42
Study: 26629812

Group type: EXPERIMENTAL
Intervention: Systematic follow-up by general practitioners (GPs) with written guidelines, consultations within one week after discharge, and regular consultations for six months.
Number of subjects: 176

Group type: COMPARATOR
Intervention: Treatment as usual (control group).
Number of subjects: 176

Group type: EXPERIMENTAL
Intervention: Systematic follow-up by GPs.
Number of subjects: 176
Study: 23158787

Group type: EXPERIMENTAL
Intervention: Communication Skills Training (CST)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Control group (no CST)
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: CST
Number of subjects: 56
Study: 21401662

Group type: EXPERIMENTAL
Intervention: Functional Electrical Stimulation (FES) therapy
Number of subjects: 22

Group type: COMPARATOR
Intervention: Conventional occupational therapy
Number of subjects: 22
Study: 18954649

Group type: EXPERIMENTAL
Intervention: Off-pump coronary artery bypass grafting
Number of subjects: 80

Group type: COMPARATOR
Intervention: On-pump coronary artery bypass grafting
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Arachidonic acid-induced platelet aggregation in off-pump group
Number of subjects: 80

Group type: COMPARATOR
Intervention: Arachidonic acid-induced platelet aggregation in on-pump group
Number of subjects: 80
Study: 16549220

Group type: EXPERIMENTAL
Intervention: 10mg Corosolic acid (CRA)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 31
Study: 14666739

Group type: EXPERIMENTAL
Intervention: Crest SpinBrush Pro
Number of subjects: 40

Group type: COMPARATOR
Intervention: Oral-B CrossAction Power
Number of subjects: 40
Study: 10870149

Group type: EXPERIMENTAL
Intervention: Transpedicular fixation during posterolateral fusion (n = 37)
Number of subjects: 77

Group type: COMPARATOR
Intervention: Posterolateral fusion without transpedicular fixation (n = 40)
Number of subjects: 77
Study: 8839728

Group type: EXPERIMENTAL
Intervention: Oral exhaled NO in asthmatic children
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Nasal exhaled NO in asthmatic children
Number of subjects: 47

Group type: COMPARATOR
Intervention: Oral exhaled NO in healthy controls
Number of subjects: 47

Group type: COMPARATOR
Intervention: Nasal exhaled NO in healthy controls
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Correlation between oral exhaled NO and FeV1
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Correlation between oral/nasal exhaled NO and other markers
Number of subjects: 47
Study: 1538504

Group type: EXPERIMENTAL
Intervention: Duoderm CGF plus compression (Coban wrap)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Unna's boot
Number of subjects: 30
Study: 6148345

Group type: EXPERIMENTAL
Intervention: Low dose propranolol
Number of subjects: 40
Study: 31206358

Group type: EXPERIMENTAL
Intervention: Statin therapy (rosuvastatin)
Number of subjects: 683

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 683
Study: 28852915

Group type: EXPERIMENTAL
Intervention: Personal phone call recommending vaccinations
Number of subjects: 210

Group type: EXPERIMENTAL
Intervention: Standardized mailed letter recommending vaccinations
Number of subjects: 210

Group type: COMPARATOR
Intervention: Control group with no vaccination information
Number of subjects: 210
Study: 26780033

Group type: EXPERIMENTAL
Intervention: MenACWY-TT booster vaccination
Number of subjects: 0

Group type: COMPARATOR
Intervention: MenC-CRM197 booster vaccination
Number of subjects: 0
Study: 24931900

Group type: EXPERIMENTAL
Intervention: On-demand system
Number of subjects: 100

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 100
Study: 22157100

Group type: EXPERIMENTAL
Intervention: Intra-articular dexamethasone administration after arthrocentesis
Number of subjects: 28

Group type: COMPARATOR
Intervention: Saline (placebo) administration after arthrocentesis
Number of subjects: 28
Study: 19751247

Group type: EXPERIMENTAL
Intervention: Prucalopride 0.5 mg once daily for 28 days
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: Prucalopride 1 mg once daily for 28 days
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: Prucalopride 2 mg once daily for 28 days
Number of subjects: 89

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 89
Study: 17921900

Group type: EXPERIMENTAL
Intervention: HSA-coated titanium tympanostomy tubes
Number of subjects: 149

Group type: COMPARATOR
Intervention: Uncoated titanium tympanostomy tubes
Number of subjects: 149
Study: 15611506

Group type: EXPERIMENTAL
Intervention: Pain education intervention (culture-specific video and booklet on pain management)
Number of subjects: 97

Group type: COMPARATOR
Intervention: Control group (video and booklet on nutrition)
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: Pain education intervention
Number of subjects: 97

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 97
Study: 11374750

Group type: EXPERIMENTAL
Intervention: State-induced anger
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study: 9724117

Group type: EXPERIMENTAL
Intervention: Gliosarcoma
Number of subjects: 18

Group type: COMPARATOR
Intervention: GBM (entire group)
Number of subjects: 18

Group type: COMPARATOR
Intervention: GBM (control group)
Number of subjects: 18
Study: 8880102

Group type: EXPERIMENTAL
Intervention: 0.3 ppm NO2 for 1 h with moderate intermittent exercise
Number of subjects: 22

Group type: COMPARATOR
Intervention: Air exposure
Number of subjects: 22
Study: 2124179

Group type: EXPERIMENTAL
Intervention: Levonorgestrel 20 mcg/day (LNg 20)
Number of subjects: 2245

Group type: COMPARATOR
Intervention: Copper T 380Ag
Number of subjects: 2245
Study: 400246

Group type: EXPERIMENTAL
Intervention: Therapist-conducted, face-to-face progressive, deep-muscle relaxation training for 10 weekly sessions
Number of subjects: 29

Group type: COMPARATOR
Intervention: Progressive deep-muscle relaxation therapy conducted mainly by home use of audio cassettes
Number of subjects: 29

Group type: COMPARATOR
Intervention: Nonspecific individual psychotherapy for 10 weekly sessions
Number of subjects: 29
Study: 31915039

Group type: EXPERIMENTAL
Intervention: JIAH intervention (adolescent groups, youth leadership activities, and livelihood promotion)
Number of subjects: 40676

Group type: COMPARATOR
Intervention: Livelihood promotion only (control group)
Number of subjects: 40676
Study: 31665156

Group type: EXPERIMENTAL
Intervention: Resubmission process for scientific papers
Number of subjects: 288

Group type: EXPERIMENTAL
Intervention: Time spent on reformatting
Number of subjects: 288

Group type: EXPERIMENTAL
Intervention: Economic burden of reformatting
Number of subjects: 288

Group type: EXPERIMENTAL
Intervention: Desire for reform
Number of subjects: 288
Study: 26158794

Group type: EXPERIMENTAL
Intervention: Tofogliflozin alone
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: Co-administration of tofogliflozin and anti-T2DM drugs
Number of subjects: 108

Group type: COMPARATOR
Intervention: Anti-T2DM drugs alone
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: Tofogliflozin
Number of subjects: 108
Study: 23823042

Group type: EXPERIMENTAL
Intervention: Dynamic hip screw (DHS) with anti-rotation screw (group 2)
Number of subjects: 65

Group type: COMPARATOR
Intervention: Dynamic hip screw (DHS) alone (group 1)
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Both groups (group 1 and group 2)
Number of subjects: 65
Study: 21413892

Group type: EXPERIMENTAL
Intervention: Mammography screening
Number of subjects: 9
Study: 19539103

Group type: EXPERIMENTAL
Intervention: Single dose of 30 mg duloxetine
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Single dose of 60 mg duloxetine
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Single dose of 90 mg duloxetine
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Multiple doses of 30 mg duloxetine (twice daily for 7 days)
Number of subjects: 30
Study: 16427737

Group type: EXPERIMENTAL
Intervention: CRPS-affected site
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: CRPS-affected sites
Number of subjects: 18

Group type: COMPARATOR
Intervention: Control subjects
Number of subjects: 18
Study: 15261565

Group type: EXPERIMENTAL
Intervention: Cyclophosphamide 800 mg/m2 plus methylprednisolone 1 g IV (CY/MP)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Methylprednisolone (MP) once monthly for 6 months
Number of subjects: 0
Study: 11385201

Group type: EXPERIMENTAL
Intervention: Carisolv
Number of subjects: 16

Group type: COMPARATOR
Intervention: Air-motor
Number of subjects: 16
Study: 9337506

Group type: EXPERIMENTAL
Intervention: Modified Cue Exposure (CE)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Cognitive-Behavior Therapy (CBT)
Number of subjects: 0
Study: 1437473

Group type: EXPERIMENTAL
Intervention: Two standard drifting gratings (F/F)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Two non-Fourier drifting gratings (NF/NF)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: One standard and one non-Fourier drifting grating (F/NF)
Number of subjects: 0
Study: 3896288

Group type: EXPERIMENTAL
Intervention: Vincristine
Number of subjects: 530

Group type: COMPARATOR
Intervention: No further treatment (Control)
Number of subjects: 530

Group type: EXPERIMENTAL
Intervention: First line therapy (Melphalan and Prednisone)
Number of subjects: 530

Group type: EXPERIMENTAL
Intervention: Continuation of first line therapy for a further year
Number of subjects: 530
Study: 29215971

Group type: EXPERIMENTAL
Intervention: Mediterranean-style diet (MedDiet) supplemented with fish oil, received fortnightly food hampers and MedDiet cooking workshops for 3 months and fish oil supplements for 6 months
Number of subjects: 152

Group type: COMPARATOR
Intervention: Control group attending social groups fortnightly for 3 months
Number of subjects: 152
Study: 30021556

Group type: EXPERIMENTAL
Intervention: Custom foot orthoses and new shoes
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Shoe group (sham insole with new shoes)
Number of subjects: 60
Study: 26572633

Group type: EXPERIMENTAL
Intervention: Tourniquet application
Number of subjects: 34

Group type: COMPARATOR
Intervention: Non-tourniquet application
Number of subjects: 34
Study: 25126031

Group type: EXPERIMENTAL
Intervention: ASVAuto
Number of subjects: 18

Group type: COMPARATOR
Intervention: bilevel-ST
Number of subjects: 18
Study: 22173041

Group type: EXPERIMENTAL
Intervention: Daily mild home exercises (calisthenics focusing on balance-control, low-back-connected musculature) for 15 minutes daily over 2 months
Number of subjects: 30

Group type: COMPARATOR
Intervention: Matched control group observed and examined only
Number of subjects: 30
Study: 20202636

Group type: EXPERIMENTAL
Intervention: 1000 mg Mycophenolate mofetil (MMF) BD for at least 2 weeks
Number of subjects: 21

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21
Study: 17921409

Group type: EXPERIMENTAL
Intervention: Tea drinkers
Number of subjects: 1500

Group type: COMPARATOR
Intervention: Non-tea drinkers
Number of subjects: 1500
Study: 15806748

Group type: EXPERIMENTAL
Intervention: Pregabalin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 12232562

Group type: EXPERIMENTAL
Intervention: Venoruton (HR) 2 g/day for 8 weeks
Number of subjects: 90

Group type: COMPARATOR
Intervention: Daflon (500 mg) three tablets daily every 8 hours
Number of subjects: 90
Study: 10091293

Group type: EXPERIMENTAL
Intervention: Low molecular weight heparin (5000 U anti-Xa; Fragmin P forte) s.c.
Number of subjects: 200

Group type: COMPARATOR
Intervention: Dose-adjusted coumarin (Marcumar) p.o.
Number of subjects: 200
Study: 8526279

Group type: COMPARATOR
Intervention: 5-pound test for control subjects
Number of subjects: 116

Group type: EXPERIMENTAL
Intervention: 5-pound test for affected knees
Number of subjects: 116

Group type: EXPERIMENTAL
Intervention: Diagnostic determinant for peripatellar imbalance
Number of subjects: 116
Study: 2047886

Group type: EXPERIMENTAL
Intervention: Close prospective, long-term follow-up of PSC patients
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Statistical survival modeling
Number of subjects: 0
Study: 7471600

Group type: EXPERIMENTAL
Intervention: Atenolol 50 mg, 100 mg, 200 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Sotalol 50 mg, 100 mg, 200 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Metoprolol 400 mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Metoprolol 50 mg, 100 mg, 200 mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 30554135

Group type: EXPERIMENTAL
Intervention: SMART-CPT (CogSMART+CPT)
Number of subjects: 100

Group type: COMPARATOR
Intervention: CPT (Cognitive Processing Therapy)
Number of subjects: 100
Study: 27888578

Group type: EXPERIMENTAL
Intervention: UltraBLOX™ radiation attenuating hand cream
Number of subjects: 2

Group type: COMPARATOR
Intervention: Unshielded dosimeter (control)
Number of subjects: 2
Study: 26549399

Group type: EXPERIMENTAL
Intervention: SX-1001 (low-intensity pulsed ultrasound device)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 44
Study: 24119605

Group type: EXPERIMENTAL
Intervention: Triamcinolone (TA) 20 mg-soaked bioabsorbable dressing
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (saline-impregnated dressing)
Number of subjects: 20
Study: 21282685

Group type: EXPERIMENTAL
Intervention: Sealant with DMAE‐CB (1% by weight)
Number of subjects: 3

Group type: COMPARATOR
Intervention: Negative control sealant (Helioseal without DMAE‐CB)
Number of subjects: 3

Group type: COMPARATOR
Intervention: Positive control sealant (Helioseal F with fluoride-releasing resin)
Number of subjects: 3
Study: 19634512

Group type: EXPERIMENTAL
Intervention: Iron(III) hydroxide polymaltose complex (IPC, Maltofer) containing 100 mg of elemental iron, 6 days a week for 8 months
Number of subjects: 4

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: Iron(III) hydroxide polymaltose complex (IPC, Maltofer)
Number of subjects: 4
Study: 17602935

Group type: EXPERIMENTAL
Intervention: Carvedilol
Number of subjects: 1106

Group type: COMPARATOR
Intervention: Metoprolol tartrate
Number of subjects: 1106

Group type: COMPARATOR
Intervention: Metoprolol tartrate (BMI >30 kg/m2)
Number of subjects: 1106

Group type: COMPARATOR
Intervention: Metoprolol tartrate (BMI >40 kg/m2)
Number of subjects: 1106
Study: 15046728

Group type: EXPERIMENTAL
Intervention: Physostigmine (anticholinesterase)
Number of subjects: 0
Study: 11133598

Group type: EXPERIMENTAL
Intervention: DCLHb (1 g/kg)
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: DCLHb (936 +/- 276 mg/kg)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Packed red blood cells
Number of subjects: 26